"The U.S. is out of step with the rest of the world in allowing prescription drugs to be advertised to consumers", says Vera Hassner Sharav of the Alliance for Human Research Protection. "A coalition of non-profit organizations has drafted legislation to ban direct to consumer advertising because the ads do not promote public health, they increase the cost of drugs and the number of unnecessary prescriptions, which is expensive to taxpayers, and can be harmful or deadly to patients.
According to this article, the USA and New Zealand actually are the only industrialized nations to allow direct-to-consumer advertising for pharmaceutical medicines, and New Zealand is already mulling a ban.
Far from helping us be more healthy, the ads actually allow drug makers to increase sales of often useless and - even worse - dangerous drugs and as a result, pharmaceutical industry has boomed while the health of Americans is in a deplorable state, with even the survival rate of newborns approaching third world levels.
A coalition is being built to support the legislation, which calls for a stop to public drug advertising. The alert comes from Leonore Tiefer, Ph.D. Professor of Psychiatry at the NYU School of Medicine.
You can weigh in on this issue, going to www.stopdrugads.org
From: Leonore Tiefer
Sent: Monday, May 08, 2006
Subject: Legislation to ban DTCA in U.S.
Colleagues,
Commercial Alert, the National Women's Health Network and Physicians for a National Health Program are building a national coalition in support of legislation to ban direct-to-consumer (DTC) prescription drug advertising in the United States.
The text of the proposed bill ("Public Health Protection Act") is attached.
For more information about Commercial Alert's work against DTC prescription drug advertising, see their web page on DTC ads, www.stopdrugads.org.
Last year, more than 200 medical school professors endorsed their statement calling for an end to DTC prescription drug advertising.
They are looking for U.S.-based organizations to endorse the legislation.
Please email the name of your organization to Marnie Glickman.
Leonore
--
Leonore Tiefer, Ph.D.
Clinical Assoc. Professor, Psychiatry
NYU School of Medicine
163 Third Ave. #183
New York, NY 10003
Tel: 212-533-2774
~~~~~~~~~~~~~~~~~~
Public Health Protection Act
We call on Congress to enact the Public Health Protection Act to prohibit
direct-to-consumer marketing of prescription drugs.
Background:
In 2004, pharmaceutical companies spent more than $4 billion in advertising for prescription drugs. This advertising does not promote public health. It increases the
cost of drugs and the number of unnecessary prescriptions, which is expensive to taxpayers, and can be harmful or deadly to patients.
Provision 1:
Direct-to-consumer advertisements of prescription drugs are prohibited, including "reminder advertisements," and "help-seeking advertisements" that direct people to
websites that are intended to promote the sale of particular prescription drugs. An exception is created for print advertising that presents only the names and prices of
prescription drugs, or informs consumers that certain prescription drugs are available at a certain location. Ads may not use emotive imagery that is not primarily educational.
Provision 2:
If provision 1 is held unconstitutional, the following provisions will immediately become effective:
a. Direct-to-consumer advertisements for a prescription drug shall include additional warnings appropriate to the drug to inform consumers that
(1) this drug was approved based on testing that included fewer than [typically 3000] people, and it may be dangerous to your health in ways that this limited research has not yet revealed; and,
(2) the Food and Drug Administration does not certify that this drug is more effective, safer or cheaper than other drugs in its class.
b. Direct-to-consumer advertising of prescription drugs shall not be tax deductible.
c. Pharmaceutical companies shall be subject to a 3% windfall profits tax, which shall be dedicated to a fund, controlled by the National Institutes of Health, for conducting studies on comparative benefits of drugs (also compared to nonpharmaceutical
interventions) and a mechanism for publicly disseminating those results, including academic detailing and advertising.
If any portion of provision 2 is held to be unconstitutional, the other provisions shall not be affected.
Endorsers:
Action Coalition for Media Education
Commercial Alert
Connecticut Alliance for Retired Americans
Essential Action
Florida Alliance for Retired Americans
Just Health Care
Maine Council of Senior Citizens-Alliance for Retired Americans (MCSC-ARA)
Maryland NOW
National Women's Health Network
New View Campaign for Women's Sexual Problems (FSD-Alert.org)
Pennsylvanians United for Reform in Health Care (PURe-HC)
Pennsylvanians United for Single Payer Healthcare (PUSH)
Physicians for a National Health Program
Prescription Access Litigation Project